Recombinant platelet factor-4: Began two Phase I/II

Repligen Corp. (RGEN) Product: Recombinant platelet factor-4 (rPF4) Indication: Inhibitor of tumor growth in colon carcinoma; and in malignant melanoma and renal cell carcinoma Status: Began two Phase...